Effect of bacille Calmette-Guerin vaccination on C-peptide secretion in children newly diagnosed with IDDM

Diabetes Care

Volumn 21, Issue 10, 1998, Pages 1691-1693

  Elliott, John F ^a   Marlin, Karen L ^a   Couch, Robert M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; C PEPTIDE;

ADOLESCENT; ARTICLE; AUTOIMMUNITY; CELL FUNCTION; CHILD; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTRADERMAL DRUG ADMINISTRATION; MALE; PANCREAS ISLET BETA CELL; PEPTIDE SYNTHESIS; VACCINATION;

ADOLESCENT; BCG VACCINE; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; DOUBLE-BLIND METHOD; FASTING; FEMALE; FOLLOW-UP STUDIES; GLUCAGON; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; MALE; TIME FACTORS;

EID: 0031656149     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.10.1691     Document Type: Article

References (13)

1. Thai A-C, Eisenbarth GS: Natural history of IDDM. Diabetes Rev 1:1-14, 1993
2. Atkinson MA, Maclaren NK: The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331:1428-1436, 1994
3. Styler JS, Marks JB: Immune intervention in type 1 diabetes mellitus. Diabetes Rev 1:15-42, 1993
4. Sadelain MW, Qin HY, Lauzon J, Singh B: Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583-589, 1990
5. Harada M, Kishimoto Y, Makino S: Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination. Diabetes Res Clin Pract 8:85-89, 1990
6. Sadelain MW, Qin H, Sumoski W, Parfrey N, Singh B, Rabinovitch A: Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmun 3:671-680, 1990
7. Shehadeh N, Calcinaro F, Bradley BJ, Bruchlim I, Vardi P, Lafferty KJ: Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 343:706-707, 1994
8. Klingensmith G, Allen H, Hayward A, Stohry L, Humber C, Jensen P, Simcoes E, Chase HP: Vaccination with BCG at diagnosis does not alter the course of IDDM (Abstract). Diabetes 46 (Suppl. 1):193A, 1997
9. Schiffrin A, Suissa S, Weitzner G, Poussier P, Lalla D: Factors predicting course of β-cell function in IDDM. Diabetes Care 15:997-1001, 1992
10. DCCT Research Group: Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual b-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial. J Clin Endrocrinol Metab 65:30-36, 1987
11. Vazeou A, Lafferty K, Pergantou E, Spanos E, Gazda L, Bansocas C: BCG vaccine modulates autoimmune process in newly diagnosed IDDM patients (Abstract). Herm Res 48 (Suppl. 2):7, 1997
12. Wang T, Singh B, Warnock GL, Rajotte RV: Prevention of recurrence of IDDM in islettransplanted diabetic NOD mice by adjuvant immunotherapy Diabetes 41:114-117, 1992
13. Dahlquist G, Gothefors L: The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 38:873-874, 1995